Agile Therapeutics, Inc. (AGRX) Social Stream
AGILE THERAPEUTICS INC (AGRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AGILE THERAPEUTICS INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
AGRX reports an average of 11,199.02% for its upside potential over the past 41 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
AGRX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
AGRX's average broker recommendation rating improved by 0 over the prior 153 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AGRX as an investment opportunity.
- AGRX has a higher upside potential (average analyst target price relative to current price) than 881.16% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, AGILE THERAPEUTICS INC's average analyst price target is higher than 371.86% of them.
- In terms of how AGILE THERAPEUTICS INC fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -677.28% of that group.
- AGRX has a higher number of analysts covering the stock than 137.16% of Healthcare stocks.
Make investment decisions regarding AGRX using the data that counts. Try POWR Ratings for free.